Clinical Trial Update: Treatment and Biomarker Testing Patterns,Treatment Outcomes in a/m NSCLC With and Without Actionable Genomic Alterations

View source ↗

Summary

An AstraZeneca-sponsored clinical trial update evaluating treatment and biomarker testing patterns and treatment outcomes in non-small cell lung cancer with and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Non-small-cell Lung Cancer | Status: ACTIVE_NOT_RECRUITING